dacarbazine has been researched along with Cancer, Embryonal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, FC; Chang, KP; Chen, HH; Chen, YW; Guo, WY; Ho, DM; Hu, YW; Lai, IC; Lee, YY; Liang, ML; Shiau, CY; Wong, TT; Yen, SH | 1 |
| Adamson, PC; Blaney, SM; Dancey, JE; Gilbertson, RJ; Hamilton, M; Ingle, AM; Jakacki, RI; Krailo, MD; Tersak, J; Voss, SD | 1 |
| Fukushima, T; Inoue, T; Kawaguchi, H; Komatsu, F; Komatsu, M; Nabeshima, K; Oshiro, S; Tsugu, H | 1 |
| Aparicio, J; Garcia del Muro, X; Germa-Lluch, JR; Horwich, A; Huddart, R; Maroto, P; Paz Ares, L | 1 |
| Carmichael, M; Collen, J; Wroblewski, T | 1 |
| Heberling, D; Höffken, H; Kühn, W; Rummel, HH | 1 |
| Fanning, J; Piver, MS; Tsukada, Y; Zylstra, S | 1 |
2 trial(s) available for dacarbazine and Cancer, Embryonal
| Article | Year |
|---|---|
Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Diarrhea; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Humans; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Osteosarcoma; Quinazolines; Rhabdomyosarcoma; Temozolomide | 2008 |
Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumors.
Topics: Adult; Antineoplastic Agents; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Survival Analysis; Temozolomide; Testicular Neoplasms; Treatment Outcome | 2011 |
5 other study(ies) available for dacarbazine and Cancer, Embryonal
| Article | Year |
|---|---|
Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniospinal Irradiation; Dacarbazine; Disease-Free Survival; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Radiation-induced astrocytoma with rapid malignant transformation: case report.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Basal Ganglia; Brain Neoplasms; Cell Transformation, Neoplastic; Cerebellar Neoplasms; Dacarbazine; Fatal Outcome; Gait Disorders, Neurologic; Humans; Hydrocephalus; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Temozolomide; Time Factors; Young Adult | 2011 |
Metastatic malignant teratoma arising from mediastinal nonseminomatous germ cell tumor: a case report.
Topics: Adult; Dacarbazine; Doxorubicin; Fatal Outcome; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Mesna; Neoplasms, Germ Cell and Embryonal; Teratoma | 2008 |
[Morphology and clinical aspects of malignant mixed müllerian tumors of the corpus uteri].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Postoperative Care; Prognosis; Uterine Neoplasms; Vincristine | 1982 |
Pathologic complete response of advanced ovarian mixed mesodermal tumor to cisplatin, adriamycin and dacarbazine: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Female; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms | 1989 |